Ankylosing Spondylitis Disease Activity Score (ASDAS) by anti-drug

Ankylosing spondylitis remission: Definition and more

Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis

Concurrent Intervention With Exercises and Stabilized Tumor Necrosis Factor Inhibitor Therapy Reduced the Disease Activity in Patients With Ankylosing Spondylitis – topic of research paper in Clinical medicine. Download scholarly article PDF

Nutrients, Free Full-Text

Disease activity state by ASDAS-CRP vs. ASDAS-qCRP (A) and ASDAS-CRP

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Ankylosing spondylitis: etiology, pathogenesis, and treatments

Ankylosing spondilitis

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3